Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer

被引：0
|
作者：
Gonzalez, R. [1 ]
Gockley, A. A. [2 ]
Melamed, A. [1 ]
Clark, R. M. [2 ]
Schorge, J. O. [1 ]
del Carmen, M. G. [3 ]
Berkowitz, R. S. [4 ]
Horowitz, N. S. [4 ]
Muto, M. G. [5 ]
Worley, M. J., Jr. [6 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Boston, MA USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.477
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
467
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [31] DESIGN OF THE BETA-BLOCKER EVALUATION SURVIVAL TRIAL (BEST)
    ANDERSON, JL
    GREENBERG, B
    BODEN, W
    KRAUSESTEINRAUF, H
    BRISTOW, MR
    ZELIS, R
    CARSON, P
    LAVORI, PW
    COLLING, C
    LINDENFELD, J
    DOMANSKI, MJ
    DEYKIN, D
    EICHHORN, EJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (17): : 1220 - 1223
  • [32] Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study
    Kirkegard, Jakob
    Cronin-Fenton, Deirdre
    Lund, Andrea
    Mortensen, Frank Viborg
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [33] Beta-Blocker Use And Survival After Pulmonary Rehabilitation In Patients With Chronic Lung Diseases
    Varadi, R. G.
    Goldstein, R. S.
    Redelmeier, D. A.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [34] Prevention of pancreatic cancer by the beta-blocker propranolol
    Al-Wadei, Hussein A.
    Al-Wadei, Mohammed H.
    Schuller, Hildegard M.
    ANTI-CANCER DRUGS, 2009, 20 (06) : 477 - 482
  • [35] ERGOMETRIC STUDY OF ASSOCIATION OF A BETA-BLOCKER AND A NITRATE DERIVATIVE
    JULLIEN, G
    NOUVELLE PRESSE MEDICALE, 1978, 7 (31): : 2727 - 2731
  • [36] Beta-Blocker Use at Discharge in Patients Hospitalized for Heart Failure Is Associated With Improved Survival
    Tsuchihashi-Makaya, Miyuki
    Kinugawa, Shintaro
    Yokoshiki, Hisashi
    Hamaguchi, Sanae
    Yokota, Takashi
    Goto, Daisuke
    Goto, Kazutomo
    Takeshita, Akira
    Tsutsui, Hiroyuki
    CIRCULATION JOURNAL, 2010, 74 (07) : 1364 - 1371
  • [37] Impact of beta-blocker medication use on prostate cancer survival: Results from a single-institution cancer registry.
    Kohli, Manish
    Nandy, Debashis
    Haley, Charlotte
    Tan, Winston
    Lee, Adam
    Cerhan, James Robert
    Tindall, Donald J.
    Pathak, Jyotishman
    Breitenstein, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population
    Zahalka, Ali H.
    Fram, Ethan
    Lin, Wilson
    Mohn, Larkin
    Frenette, Paul S.
    Agalliu, Ilir
    Watts, Kara L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (10) : 794.e11 - 794.e16
  • [39] Association between beta-blocker use and fracture risk: The Dubbo Osteoporosis Epidemiology Study
    Yang, Shuman
    Nguyen, Nguyen D.
    Center, Jacqueline R.
    Eisman, John A.
    Nguyen, Tuan V.
    BONE, 2011, 48 (03) : 451 - 455
  • [40] Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis
    Leung, K. L.
    Fong, Winnie
    Freedman, Ben
    Bajorek, Beata
    Lee, Vivian W. Y.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (01) : 27 - 34
12345